SPECX
Alger Spectra Fund Class A
$33.15
Alger Spectra Fund Class A (SPECX) Technical Analysis
Summary of all the Indicators
SummarySell
15Bearish
2Neutral
5Bullish
OscillatorsBuy
3Bearish
2Neutral
5Bullish
Moving AveragesStrong Sell
12Bearish
0Neutral
0Bullish
1 Day timeframe · Data as of Nov 13, 2026
- Alger Spectra Fund Class A’s (SPECX) Moving Averages Convergence Divergence (MACD) indicator is -0.97, suggesting Alger Spectra Fund Class A is a Buy.
- Alger Spectra Fund Class A’s (SPECX) 20-Day exponential moving average is 34.70, while Alger Spectra Fund Class A’s (SPECX) share price is $33.15, making it a Sell.
- Alger Spectra Fund Class A’s (SPECX) 50-Day exponential moving average is 35.87, while Alger Spectra Fund Class A’s (SPECX) share price is $33.15, making it a Sell.
Alger Spectra Fund Class A (SPECX) Pivot Points
1 Day timeframe · Data as of Nov 13, 2026
| Name | S3 | S2 | S1 | Pivot Points | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Classic | 31.08 | 32.32 | 32.94 | 34.18 | 34.80 | 36.04 | 36.66 |
| Fibonacci | 32.32 | 33.03 | 33.47 | 34.18 | 34.89 | 35.33 | 36.04 |
Alger Spectra Fund Class A (SPECX) Moving Averages
1 Day timeframe · Data as of Nov 13, 2026
| Period | Simple | Exponential |
|---|---|---|
| MA5 | 33.56Sell | 33.54Sell |
| MA10 | 33.80Sell | 33.92Sell |
| MA20 | 34.75Sell | 34.70Sell |
| MA50 | 36.58Sell | 35.87Sell |
| MA100 | 36.68Sell | 36.24Sell |
| MA200 | 35.46Sell | 35.61Sell |
- Alger Spectra Fund Class A’s (SPECX) 10-Day exponential moving average is 33.92, while Alger Spectra Fund Class A’s (SPECX) share price is $33.15, making it a Sell.
- Alger Spectra Fund Class A’s (SPECX) 100-Day exponential moving average is 36.24, while Alger Spectra Fund Class A’s (SPECX) share price is $33.15, making it a Sell.
- Alger Spectra Fund Class A’s (SPECX) stock price is $33.15 and Alger Spectra Fund Class A’s (SPECX) 50-day simple moving average is 36.58, creating a Sell signal.
- Alger Spectra Fund Class A’s (SPECX) stock price is $33.15 and Alger Spectra Fund Class A’s (SPECX) 100-day simple moving average is 36.68, creating a Sell signal.
- Alger Spectra Fund Class A’s (SPECX) stock price is $33.15 and Alger Spectra Fund Class A’s (SPECX) 200-day simple moving average is 35.46, creating a Sell signal.
Alger Spectra Fund Class A (SPECX) Technical Analysis
1 Day timeframe · Data as of Nov 13, 2026
| Name | Value | Action |
|---|---|---|
| RSI (14) | 36.49 | Neutral |
| STOCH (9,6) | 19.75 | Buy |
| STOCHRSI (14) | 13.36 | Buy |
| MACD (12,26) | -0.97 | Buy |
| ADX (14) | 21.85 | Neutral |
| Williams %R | -94.30 | Buy |
| CCI (14) | -109.61 | Buy |
| ATR (14) | 2.15 | - |
| Ultimate Oscillator | 10.64 | Sell |
| ROC | -6.25 | Sell |
- Alger Spectra Fund Class A’s (SPECX) Relative Strength Index (RSI) is 36.49, creating a Neutral signal.
- Alger Spectra Fund Class A’s (SPECX) Trend Strength Indicator (ADX) is 21.85, creating a Neutral signal.
- Alger Spectra Fund Class A’s (SPECX) Commodity Channel Index (CCI) is -109.61, creating a Buy signal.
- Alger Spectra Fund Class A’s (SPECX) Price Rate of Change (ROC) is -6.25, creating a Sell signal.
unique trading strategy with a flexible screenerTry it Now!
FAQ
Is SPECX a Buy, Hold, or Sell?
Based on SPECX’s technical indicators on the 1-day timeframe as of Nov 13, 2026, SPECX is a Sell.
What is SPECX’s RSI (14)?
SPECX’s RSI (14) is 36.49, which suggests SPECX is a Neutral.
What is SPECX’s MACD?
SPECX’s MACD is -0.97, which suggests SPECX is a Buy.
What is SPECX’s 5-day moving average?
SPECX’s 5-day moving average is 33.56, which suggests SPECX is a Sell.
What is SPECX’s 20-day moving average?
SPECX 20-day moving average is 34.75, which suggests SPECX is a Sell.
What is SPECX’s 50-day moving average?
SPECX’s 50-day moving average is 36.58, which suggests SPECX is a Sell.
What is SPECX’s 200-day moving average?
SPECX’s 200-day moving average is 35.46, which suggests SPECX is a Sell.
What is SPECX’s Williams % R (14)?
SPECX’s Williams % R (14) is -94.30, which suggests SPECX is a Buy.
What is SPECX’s CCI (14)?
SPECX’s CCI (14) is -109.61, which suggests SPECX is a Buy.
